{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:22:24Z","timestamp":1769026944007,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11606-024-09195-7","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:11:15Z","timestamp":1732536675000},"page":"838-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["National Survey of Factors Associated with Physician Antibiotic Prescribing Preferences"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6400-9667","authenticated-orcid":false,"given":"Dongzhe","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Morlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Metlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"John H.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"9195_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/idr.S287792","volume":"14","author":"IA Dutescu","year":"2021","unstructured":"Dutescu IA, Hillier SA. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study. Infect Drug Resist. 2021;14:415-434. https:\/\/doi.org\/10.2147\/idr.S287792","journal-title":"Infect Drug Resist."},{"key":"9195_CR2","doi-asserted-by":"crossref","unstructured":"Holmes KK, Bertozzi S, Bloom BR, et al. Major infectious diseases: key messages from disease control priorities. Major Infect Dis. 2017.","DOI":"10.1596\/978-1-4648-0524-0_ch1"},{"issue":"10","key":"9195_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","volume":"5","author":"M Miethke","year":"2021","unstructured":"Miethke M, Pieroni M, Weber T, et al. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem. 2021;5(10):726-749. https:\/\/doi.org\/10.1038\/s41570-021-00313-1.","journal-title":"Nat Rev Chem."},{"key":"9195_CR4","doi-asserted-by":"crossref","unstructured":"Lawandi A, Kadri SS, III JHP. Focusing on antimicrobial resistant infections\u2013are we missing the forest for the trees and the patients for pathogens? Front Antibiot. 2023;2:1329081.","DOI":"10.3389\/frabi.2023.1329081"},{"key":"9195_CR5","unstructured":"World Health Organization. Global shortage of innovative antibiotics fuels emergence and spread of drug-resistance. 2021;28:2021."},{"issue":"7830","key":"9195_CR6","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/d41586-020-02884-3","volume":"586","author":"B Plackett","year":"2020","unstructured":"Plackett B. Why big pharma has abandoned antibiotics. Nature. 2020;586(7830):S50-S50.","journal-title":"Nature."},{"issue":"5","key":"9195_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","volume":"18","author":"U Theuretzbacher","year":"2020","unstructured":"Theuretzbacher U, Outterson K, Engel A, Karl\u00e9n A. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020;18(5):275-285. https:\/\/doi.org\/10.1038\/s41579-019-0288-0.","journal-title":"Nat Rev Microbiol."},{"key":"9195_CR8","first-page":"7940","volume":"305","author":"M Hellamand","year":"2020","unstructured":"Hellamand M, Rafiqi F. Evidence shows the antibiotics market is failing, but here is how it can be revived. Pharm J. 2020;305:7940.","journal-title":"Pharm J."},{"issue":"5","key":"9195_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","volume":"18","author":"C \u00c5rdal","year":"2020","unstructured":"\u00c5rdal C, Balasegaram M, Laxminarayan R, et al. Antibiotic development \u2014 economic, regulatory and societal challenges. Nat Rev Microbiol. 2020;18(5):267-274. https:\/\/doi.org\/10.1038\/s41579-019-0293-3.","journal-title":"Nat Rev Microbiol."},{"key":"9195_CR10","unstructured":"Congressional Budget Office. Research and development in the pharmaceutical industry. https:\/\/www.cbo.gov\/publication\/57126. Accessed 18 Jan 2024."},{"issue":"7821","key":"9195_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/d41586-020-02418-x","volume":"584","author":"M McKenna","year":"2020","unstructured":"McKenna M. The antibiotic paradox: why companies can't afford to create life-saving drugs. Nature. 2020;584(7821):338-342.","journal-title":"Nature."},{"key":"9195_CR12","doi-asserted-by":"publisher","unstructured":"Darrow JJ, Kesselheim AS. Incentivizing Antibiotic Development: Why Isn't the Generating Antibiotic Incentives Now (GAIN) Act Working? Open Forum Infect Dis. 2020;7(1):ofaa001. https:\/\/doi.org\/10.1093\/ofid\/ofaa001.","DOI":"10.1093\/ofid\/ofaa001"},{"key":"9195_CR13","doi-asserted-by":"publisher","unstructured":"Deak D, Outterson K, Powers JH, Kesselheim AS. Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010\u20132015. Ann Intern Med. 6 2016;165(5):363\u201372. https:\/\/doi.org\/10.7326\/m16-0291.","DOI":"10.7326\/m16-0291"},{"issue":"9","key":"9195_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/infdis\/jiaa536","volume":"223","author":"MS Sinha","year":"2021","unstructured":"Sinha MS, Powers JH, Kesselheim AS. The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics. J Infect Dis. 2021;223(9):1506-1509. https:\/\/doi.org\/10.1093\/infdis\/jiaa536","journal-title":"J Infect Dis."},{"issue":"2","key":"9195_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1377\/hlthaff.2014.1003","volume":"34","author":"K Outterson","year":"2015","unstructured":"Outterson K, Powers JH, Daniel GW, McClellan MB. Repairing the broken market for antibiotic innovation. Health affairs. 2015;34(2):277-285.","journal-title":"Health affairs."},{"issue":"9","key":"9195_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/13696998.2020.1772797","volume":"23","author":"RL Mendoza","year":"2020","unstructured":"Mendoza RL. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics. J Med Econ. 2020;23(9):915-922.","journal-title":"J Med Econ."},{"issue":"6","key":"9195_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/0272989x02238297","volume":"22","author":"JP Metlay","year":"2002","unstructured":"Metlay JP, Shea JA, Asch DA. Antibiotic Prescribing Decisions of Generalists and Infectious Disease Specialists: Thresholds for Adopting New Drug Therapies. Med Decis Making. 2002;22(6):498-505. https:\/\/doi.org\/10.1177\/0272989x02238297.","journal-title":"Med Decis Making."},{"issue":"2","key":"9195_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1525-1497.2002.10711.x","volume":"17","author":"JP Metlay","year":"2002","unstructured":"Metlay JP, Shea JA, Crossette LB, Asch DA. Tensions in Antibiotic Prescribing. J Gen Intern Med. 2002;17(2):87-94. https:\/\/doi.org\/10.1046\/j.1525-1497.2002.10711.x.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"9195_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2318-14-136","volume":"14","author":"LW van Buul","year":"2014","unstructured":"van Buul LW, van der Steen JT, Doncker SMMM, et al. Factors influencing antibiotic prescribing in long-term care facilities: a qualitative in-depth study. BMC Geriatrics. 2014;14(1):136. https:\/\/doi.org\/10.1186\/1471-2318-14-136.","journal-title":"BMC Geriatrics."},{"issue":"8","key":"9195_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajic.2019.02.009","volume":"47","author":"A Harris","year":"2019","unstructured":"Harris A, Chandramohan S, Awali RA, Grewal M, Tillotson G, Chopra T. Physicians' attitude and knowledge regarding antibiotic use and resistance in ambulatory settings. Am J Infect Control. 2019;47(8):864-868. https:\/\/doi.org\/10.1016\/j.ajic.2019.02.009.","journal-title":"Am J Infect Control."},{"issue":"6","key":"9195_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jama.289.6.719","volume":"289","author":"MA Steinman","year":"2003","unstructured":"Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. Jama. 2003;289(6):719-25. https:\/\/doi.org\/10.1001\/jama.289.6.719.","journal-title":"Jama."},{"key":"9195_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13017-018-0190-5","volume":"13","author":"FM Labricciosa","year":"2018","unstructured":"Labricciosa FM, Sartelli M, Correia S, et al. Emergency surgeons' perceptions and attitudes towards antibiotic prescribing and resistance: a worldwide cross-sectional survey. World J Emerg Surg. 2018;13:27. https:\/\/doi.org\/10.1186\/s13017-018-0190-5.","journal-title":"World J Emerg Surg."},{"key":"9195_CR23","doi-asserted-by":"crossref","unstructured":"Williams DJ, Hall M, Gerber JS, et al. Impact of a national guideline on antibiotic selection for hospitalized pneumonia. Pediatrics. 2017;139(4).","DOI":"10.1542\/peds.2016-3231"},{"key":"9195_CR24","doi-asserted-by":"crossref","unstructured":"Lacy BE, Xu Y, Taylor DC, et al. Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participants. Neurogastroenterol Motil. 2024:e14885.","DOI":"10.1111\/nmo.14885"},{"issue":"5","key":"9195_CR25","doi-asserted-by":"publisher","first-page":"e2316297","DOI":"10.1001\/jamanetworkopen.2023.16297","volume":"6","author":"R Morlock","year":"2023","unstructured":"Morlock R, Rose J, Powers JH. Perspectives of US Adults on Antimicrobial Trials With Noninferiority Designs. JAMA network open. 2023;6(5):e2316297-e2316297.","journal-title":"JAMA network open."},{"issue":"1","key":"9195_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245586","volume":"16","author":"R Morlock","year":"2021","unstructured":"Morlock R, Morlock A, Downen M, Shah SN. COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders. PLoS One. 2021;16(1):e0245586.","journal-title":"PLoS One."},{"key":"9195_CR27","doi-asserted-by":"crossref","unstructured":"Lacy BE, Xu Y, Taylor DC, et al. Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States. Neurogastroenterol Motil. 2024:e14903.","DOI":"10.1111\/nmo.14903"},{"issue":"8","key":"9195_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jamasurg.2021.0543","volume":"156","author":"SC Pitt","year":"2021","unstructured":"Pitt SC, Schwartz TA, Chu D. AAPOR reporting guidelines for survey studies. JAMA Surgery. 2021;156(8):785-786.","journal-title":"JAMA Surgery."},{"issue":"7","key":"9195_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034983","volume":"10","author":"RM Zetts","year":"2020","unstructured":"Zetts RM, Stoesz A, Garcia AM, et al. Primary care physicians\u2019 attitudes and perceptions towards antibiotic resistance and outpatient antibiotic stewardship in the USA: a qualitative study. BMJ Open. 2020;10(7):e034983. https:\/\/doi.org\/10.1136\/bmjopen-2019-034983.","journal-title":"BMJ Open."},{"key":"9195_CR30","doi-asserted-by":"crossref","unstructured":"Mitra-Majumdar M, Powers III JH, Brown BL, Kesselheim AS. Evidence at time of regulatory approval and cost of new antibiotics in 2016\u201319: cohort study of FDA approved drugs. BMJ Medicine. 2022;1(1).","DOI":"10.1136\/bmjmed-2022-000227"},{"issue":"5","key":"9195_CR31","doi-asserted-by":"publisher","first-page":"e218816","DOI":"10.1001\/jamanetworkopen.2021.8816","volume":"4","author":"BN Rome","year":"2021","unstructured":"Rome BN, Feldman WB, Desai RJ, Kesselheim AS. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs. JAMA Network Open. 2021;4(5):e218816-e218816. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8816.","journal-title":"JAMA Network Open."},{"key":"9195_CR32","doi-asserted-by":"publisher","unstructured":"Bibeau WS, Fu H, Taylor AD, Kwan AY. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes. J Manag Care Spec Pharm. 2016;22(11):1338\u20131347. https:\/\/doi.org\/10.18553\/jmcp.2016.22.11.1338.","DOI":"10.18553\/jmcp.2016.22.11.1338"},{"issue":"22","key":"9195_CR33","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","volume":"365","author":"NK Choudhry","year":"2011","unstructured":"Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088-97. https:\/\/doi.org\/10.1056\/NEJMsa1107913.","journal-title":"N Engl J Med."},{"issue":"4","key":"9195_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1200\/jco.2013.52.9123","volume":"32","author":"SB Dusetzina","year":"2014","unstructured":"Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4):306-11. https:\/\/doi.org\/10.1200\/jco.2013.52.9123.","journal-title":"J Clin Oncol."},{"key":"9195_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ahj.2020.12.010","volume":"233","author":"BN Rome","year":"2021","unstructured":"Rome BN, Gagne JJ, Avorn J, Kesselheim AS. Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study. Am Heart J. 2021;233:109-121. https:\/\/doi.org\/10.1016\/j.ahj.2020.12.010.","journal-title":"Am Heart J."},{"key":"9195_CR36","unstructured":"Centers for Disease Control and Prevention. Fast facts: Health and economic costs of chronic conditions.\u00a0https:\/\/www.cdc.gov\/chronic-disease\/data-research\/facts-stats\/index.html. Accessed 11 Nov 2024."},{"key":"9195_CR37","doi-asserted-by":"publisher","unstructured":"Nelson RE, Hatfield KM, Wolford H, et al. National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States. Clin Infect Dis. 2021;72(Supplement_1):S17-S26. https:\/\/doi.org\/10.1093\/cid\/ciaa158.","DOI":"10.1093\/cid\/ciaa158"},{"issue":"6","key":"9195_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamainternmed.2014.853","volume":"174","author":"KR Riggs","year":"2014","unstructured":"Riggs KR, Ubel PA. Overcoming Barriers to Discussing Out-of-Pocket Costs With Patients. JAMA Int Med. 2014;174(6):849-850. https:\/\/doi.org\/10.1001\/jamainternmed.2014.853.","journal-title":"JAMA Int Med."},{"issue":"3","key":"9195_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1200\/jop.2015.007401","volume":"12","author":"I Altomare","year":"2016","unstructured":"Altomare I, Irwin B, Zafar SY, et al. ReCAP: Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. J Oncol Pract. 2016;12(3):247-248. https:\/\/doi.org\/10.1200\/jop.2015.007401.","journal-title":"J Oncol Pract."},{"key":"9195_CR40","doi-asserted-by":"publisher","unstructured":"Shih Y-CT, Chien C-R. A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment. Cancer. 2017;123(6):928\u2013939. https:\/\/doi.org\/10.1002\/cncr.30423.","DOI":"10.1002\/cncr.30423"},{"key":"9195_CR41","doi-asserted-by":"crossref","unstructured":"Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(suppl_3):S97-S100.","DOI":"10.1093\/cid\/ciu542"},{"issue":"6","key":"9195_CR42","first-page":"1","volume":"65","author":"GV Sanchez","year":"2016","unstructured":"Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core elements of outpatient antibiotic stewardship. Morbidity and Mortality Weekly Report: Recommendations and Reports. 2016;65(6):1-12.","journal-title":"Morbidity and Mortality Weekly Report: Recommendations and Reports."},{"key":"9195_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.3307","author":"AD Sinaiko","year":"2023","unstructured":"Sinaiko AD, Sloan CE, Soto MJ, Zhao O, Lin C-T, Goss FR. Clinician Response to Patient Medication Prices Displayed in the Electronic Health Record. JAMA Int Med. 2023; https:\/\/doi.org\/10.1001\/jamainternmed.2023.3307.","journal-title":"JAMA Int Med."},{"key":"9195_CR44","unstructured":"Federal Task Force on Combating Antibiotic-Resistant Bacteria. National action plan for combating antibiotic-resistant bacteria, 2020\u20132025. https:\/\/aspe.hhs.gov\/sites\/default\/files\/migrated_legacy_files\/196436\/CARB-National-Action-Plan-2020-2025.pdf. Accessed 11 Nov 2024."},{"key":"9195_CR45","unstructured":"Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). Portfolio product developers. https:\/\/carb-x.org\/portfolio\/portfolio-companies\/. Accessed 24 Nov 2023."},{"issue":"3","key":"9195_CR46","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.neuron.2014.10.027","volume":"84","author":"DW Choi","year":"2014","unstructured":"Choi DW, Armitage R, Brady LS, et al. Medicines for the mind: policy-based \u201cpull\u201d incentives for creating breakthrough CNS drugs. Neuron. 2014;84(3):554-563.","journal-title":"Neuron."},{"key":"9195_CR47","unstructured":"Wilkerson J. Bernie Sanders wants to replace drug patents with prizes for breakthrough medicines, https:\/\/www.statnews.com\/2023\/07\/20\/bernei-sanders-drug-patents-prizes\/. Accessed 9\/15\/2023."},{"key":"9195_CR48","unstructured":"Dall C. US lawmakers re-introduce antibiotic development legislation, https:\/\/www.cidrap.umn.edu\/antimicrobial-stewardship\/us-lawmakers-re-introduce-antibiotic-development-legislation. Accessed 9\/15\/2023."},{"key":"9195_CR49","unstructured":"Association of American Medical Colleges. The 2023 American Medical Association (AMA) physician professional data. https:\/\/www.aamc.org\/data-reports\/report\/us-physician-workforce-data-dashboard. Accessed 09\/09\/2024."},{"key":"9195_CR50","doi-asserted-by":"crossref","unstructured":"Trotman R, Kim AI, MacIntyre AT, Ritter JT, Malani AN. 2017 Infectious Diseases Society of America physician compensation survey: results and analysis. Oxford University Press US; 2018:ofy309.","DOI":"10.1093\/ofid\/ofy309"},{"issue":"9","key":"9195_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jamda.2020.07.026","volume":"21","author":"PD Sloane","year":"2020","unstructured":"Sloane PD, Tandan M, Zimmerman S. Preventive antibiotic use in nursing homes: a not uncommon reason for antibiotic overprescribing. J Am Med Dir Assoc. 2020;21(9):1181-1185.","journal-title":"J Am Med Dir Assoc."},{"key":"9195_CR52","doi-asserted-by":"crossref","unstructured":"Karakonstantis S. Is coverage of S. aureus necessary in cellulitis\/erysipelas? A literature review. Infection. 2020;48:183\u2013191.","DOI":"10.1007\/s15010-019-01382-7"},{"issue":"11","key":"9195_CR53","doi-asserted-by":"publisher","first-page":"e4499","DOI":"10.1093\/cid\/ciaa1372","volume":"73","author":"VM Vaughn","year":"2021","unstructured":"Vaughn VM, Gandhi TN, Chopra V, et al. Antibiotic overuse after hospital discharge: a multi-hospital cohort study. Clin Infect Dis. 2021;73(11):e4499-e4506.","journal-title":"Clin Infect Dis."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09195-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09195-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09195-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:13:22Z","timestamp":1764267202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09195-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["9195"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09195-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Dr. Feldman and Dr. Kesselheim report serving as a consultant for Alosa Health and Dr. Feldman for Aetion and as an expert witness in litigation against inhaler manufacturers. Dr. Kesselheim reports serving as an expert witness on behalf of a group of state attorneys general and payors in litigation against a large number of generic manufacturers related to alleged price fixing. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}